Cargando…

Sustainable Development Goal indicator for measuring availability and affordability of medicines for children: a proof-of-concept study

OBJECTIVES: To complement Sustainable Development Goal (SDG) indicator 3.b.3 that monitors access to medicines for all, a corresponding child-specific methodology was developed tailored to the health needs of children. This methodology could aid countries in monitoring accessibility to paediatric me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joosse, Iris R, Mantel-Teeuwisse, Aukje K, Suleman, Fatima, van den Ham, Hendrika A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Health Services Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106062/ https://www.ncbi.nlm.nih.gov/pubmed/37041064 http://dx.doi.org/10.1136/bmjopen-2022-065929

Ejemplares similares

Missing data on accessibility of children’s medicines
por: Joosse, Iris R, et al.
Publicado: (2022)

Availability, affordability and stock-outs of commodities for the treatment of snakebite in Kenya
por: Ooms, Gaby Isabelle, et al.
Publicado: (2021)

Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability
por: Kibira, Denis, et al.
Publicado: (2021)

Access to sexual and reproductive health commodities in East and Southern Africa: a cross-country comparison of availability, affordability and stock-outs in Kenya, Tanzania, Uganda and Zambia
por: Ooms, Gaby I., et al.
Publicado: (2020)

Evidence on the effectiveness of policies promoting price transparency - A systematic review
por: Joosse, Iris R., et al.
Publicado: (2023)

Trends in access to anti‐malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first‐line anti‐malarials and diagnostics between 2007 and 2018
por: Kibira, Denis, et al.
Publicado: (2021)

Availability, prices and affordability of UN Commission’s lifesaving medicines for reproductive and maternal health in Uganda
por: Kibira, Denis, et al.
Publicado: (2017)

Systematic reviews of ten pharmaceutical pricing policies – a research protocol
por: Tordrup, David, et al.
Publicado: (2020)

Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003–2019
por: Kusynová, Zuzana, et al.
Publicado: (2022)

Price, availability and affordability of medicines
por: Mhlanga, Brenda S., et al.
Publicado: (2014)

SDG indicator 3.b.3 – an analysis of its robustness and challenges for measuring access to medicines for children
por: Joosse, I. R., et al.
Publicado: (2023)

Assessing the impact of law enforcement to reduce over-the-counter (OTC) sales of antibiotics in low- and middle-income countries; a systematic literature review
por: Jacobs, Tom G., et al.
Publicado: (2019)

Healthcare workers’ perspectives on access to sexual and reproductive health services in the public, private and private not-for-profit sectors: insights from Kenya, Tanzania, Uganda and Zambia
por: Ooms, Gaby I., et al.
Publicado: (2022)

Donor Commitments and Disbursements for Sexual and Reproductive Health Aid in Kenya, Tanzania, Uganda and Zambia
por: Kibira, Denis, et al.
Publicado: (2021)

A comparative human rights analysis of laws and policies for adolescent contraception in Uganda and Kenya
por: Perehudoff, Katrina, et al.
Publicado: (2022)

Retail pharmacy prescription medicines’ availability, prices and affordability in Eswatini
por: Shambira, Garikai, et al.
Publicado: (2021)

Essential Medicines Are More Available than Other Medicines around the Globe
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa
por: Kusynová, Zuzana, et al.
Publicado: (2023)

Insulin prices, availability and affordability in 13 low-income and middle-income countries
por: Ewen, Margaret, et al.
Publicado: (2019)

Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
por: Narsai, Kirti, et al.
Publicado: (2012)

The Goal of Adequate Nutrition: Can It Be Made Affordable, Sustainable, and Universal?
por: McFarlane, Ian
Publicado: (2016)

Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study
por: Sagwa, Evans L, et al.
Publicado: (2014)

Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
por: Vogler, Sabine, et al.
Publicado: (2021)

Implementation strategies for occupational therapists to advance goal setting and goal management
por: Kang, Eunyoung, et al.
Publicado: (2023)

Publication trends in newspapers and scientific journals for SSRIs and suicidality: a systematic longitudinal study
por: Hernandez, J F, et al.
Publicado: (2011)

General Practitioner Time Availability Per Inhabitant Per Year: A New Indicator to Measure Access to Primary Care
por: Beer, Laura, et al.
Publicado: (2022)

Feasibility and acceptability of personalised breast cancer screening (DECIDO study): protocol of a single-arm proof-of-concept trial
por: Pons-Rodriguez, Anna, et al.
Publicado: (2020)

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Characteristics of drugs safety signals that predict safety related product information update
por: Insani, Widya N., et al.
Publicado: (2018)

The double opioid crisis: A call for balance
por: Vranken, Marjolein J.M., et al.
Publicado: (2019)

Facility versus unit level reporting of quality indicators in nursing homes when performance monitoring is the goal
por: Norton, Peter G, et al.
Publicado: (2014)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

Availability and affordability of medicines for children
por: Kazaryan, Irina, et al.
Publicado: (2015)

Balancing a sustained pursuit of nutrition, health, affordability and climate goals: exploring the case of Indonesia
por: de Pee, Saskia, et al.
Publicado: (2021)

Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
por: Moerlie, Ashwin R., et al.
Publicado: (2020)

Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil
por: Santa-Ana-Tellez, Yared, et al.
Publicado: (2015)

Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study
por: Ankrah, Daniel N. A., et al.
Publicado: (2017)

When Reality Does Not Meet Expectations—Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs
por: Callenbach, Marcelien H. E., et al.
Publicado: (2022)

Real World Data in Health Technology Assessment of Complex Health Technologies
por: Hogervorst, Milou A., et al.
Publicado: (2022)

Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort study
por: Dankers, Marloes, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qh812qb9fa4ue8ukq7ckha1loo